497 related articles for article (PubMed ID: 26401034)
1. Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.
Ku Z; Ye X; Shi J; Wang X; Liu Q; Huang Z
J Virol; 2015 Dec; 89(23):12084-95. PubMed ID: 26401034
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody.
Ye X; Fan C; Ku Z; Zuo T; Kong L; Zhang C; Shi J; Liu Q; Chen T; Zhang Y; Jiang W; Zhang L; Huang Z; Cong Y
PLoS Pathog; 2016 Mar; 12(3):e1005454. PubMed ID: 26938634
[TBL] [Abstract][Full Text] [Related]
3. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
Wang X; Ku Z; Zhang X; Ye X; Chen J; Liu Q; Zhang W; Zhang C; Fu Z; Jin X; Cong Y; Huang Z
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070691
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.
Ku Z; Ye X; Huang X; Cai Y; Liu Q; Li Y; Su Z; Huang Z
PLoS One; 2013; 8(2):e57601. PubMed ID: 23451250
[TBL] [Abstract][Full Text] [Related]
5. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71.
Ku Z; Shi J; Liu Q; Huang Z
J Virol Methods; 2012 Dec; 186(1-2):193-7. PubMed ID: 22771741
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies for diagnosis of enterovirus 71.
Xu L; Huang KJ; Ho TS; Liu CC; Lee YR; Lin CY; Shiuan D; Jiang XH
Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):386-94. PubMed ID: 24328741
[TBL] [Abstract][Full Text] [Related]
7. Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71.
Zhu L; Xu K; Wang N; Cao L; Wu J; Gao Q; Fry EE; Stuart DI; Rao Z; Wang J; Wang X
mBio; 2018 Jul; 9(4):. PubMed ID: 29970466
[TBL] [Abstract][Full Text] [Related]
8. VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection.
Fujii K; Sudaka Y; Takashino A; Kobayashi K; Kataoka C; Suzuki T; Iwata-Yoshikawa N; Kotani O; Ami Y; Shimizu H; Nagata N; Mizuta K; Matsuzaki Y; Koike S
J Virol; 2018 Aug; 92(15):. PubMed ID: 29848582
[TBL] [Abstract][Full Text] [Related]
9. Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity.
Chen Y; Li C; He D; Cheng T; Ge S; Shih JW; Zhao Q; Chen PJ; Zhang J; Xia N
Vaccine; 2013 Jan; 31(2):425-30. PubMed ID: 23088887
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.
Lim XF; Jia Q; Khong WX; Yan B; Premanand B; Alonso S; Chow VT; Kwang J
PLoS One; 2012; 7(1):e29751. PubMed ID: 22279543
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71.
Deng YQ; Ma J; Xu LJ; Li YX; Zhao H; Han JF; Tao J; Li XF; Zhu SY; Qin ED; Qin CF
Appl Microbiol Biotechnol; 2015 Sep; 99(18):7663-71. PubMed ID: 25967656
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
13. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
14.
Meng T; Jia Q; Wong SM; Chua KB
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
[TBL] [Abstract][Full Text] [Related]
15. Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity.
Jia Q; Ng Q; Chin W; Meng T; Chow VTK; Wang CI; Kwang J; He F
Sci Rep; 2017 Apr; 7():46402. PubMed ID: 28422137
[TBL] [Abstract][Full Text] [Related]
16. Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles.
Yuan S; Li G; Wang Y; Gao Q; Wang Y; Cui R; Altmeyer R; Zou G
J Virol; 2016 Jan; 90(2):741-52. PubMed ID: 26512078
[TBL] [Abstract][Full Text] [Related]
17. [Preparation of mouse monoclonal antibodies against EV71 capsid protein VP1].
Zhou Y; Xu Z; Yang L; Chen X; Duan Z; Wen J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 May; 34(5):462-468. PubMed ID: 30043737
[TBL] [Abstract][Full Text] [Related]
18. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.
Chang J; Li J; Wei W; Liu X; Liu G; Yang J; Zhang W; Yu XF
Immunol Res; 2015 Jul; 62(3):306-15. PubMed ID: 26025091
[TBL] [Abstract][Full Text] [Related]
19. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.
Kiener TK; Jia Q; Meng T; Chow VT; Kwang J
PLoS Negl Trop Dis; 2014; 8(5):e2895. PubMed ID: 24875055
[TBL] [Abstract][Full Text] [Related]
20. Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.
He F; Kiener TK; Lim XF; Tan Y; Raj KV; Tang M; Chow VT; Chen Q; Kwang J
PLoS One; 2013; 8(1):e55517. PubMed ID: 23383215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
